+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recombinant human granulocyte macrophage colony stimulating factor gm csf a phase i trial in neutropenic aids patients



Recombinant human granulocyte macrophage colony stimulating factor gm csf a phase i trial in neutropenic aids patients



Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 403




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033111071

Download citation: RISBibTeXText


Related references

Nursing care of AIDS patients in San Francisco. Tijdschrift Voor Ziekenverpleging 40(24): 718-722, 1986

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial. Blood 73(1): 31-37, 1989

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial. Journal of the National Cancer Institute 82(8): 697-703, 1990

Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 77(4): 700-711, 1991

Efficacy of recombinant granulocyte-colony stimulating factor in the long-term treatment of AIDS-related neutropenia. Recenti Progressi in Medicina 84(7-8): 526-530, 1993

Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer. Cancer 85(5): 1179-1185, 1999

Granulocyte-macrophage colony-stimulating factor in human milk. European Journal Of Pediatrics. 155(1): 69, 1996

Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatric Services 50(12): 1577-1583, 1999

Combination therapy with interferon alpha and ribavirin for hepatitis C virus infection in multiply transfused thalassaemic patients. British Journal Of Haematology. 97(suppl. 1): 47, 1997

Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study. Leukemia 8(10): 1631-1639, 1994

Phase II trial of recombinant beta interferon in advanced colorectal cancer. Cancer Treatment Reports 71(10): 965-967, 1987

Phase I trial of thermochemotherapy for brain malignancy. Cancer 56(1): 48-56, 1985

Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects. Journal of ImmunoTherapy with Emphasis on Tumor Immunology 13(4): 267-274, 1993

Recombinant human granulocyte colony-stimulating factor therapy for sepsis in infants with neutropenia. Pediatrics 103(6 Pt 1): 1310-1311, 1999